Can Early U.S. Adoption of Cancer Drugs Inform HTA Decision-Making?
Author(s)
Jonsson P1, Mpofu P2, Kent S3, Copeland A2, Groves B4, Bargo D2, Ramsey S5, Baxi S2, Adamson B2
1National Institute for Health and Care Excellence, Manchester, UK, 2Flatiron Health, New York, NY, USA, 3National Institute for Health and Care Excellence, Manchester, LAN, UK, 4National Institute for Health and Care Excellence (NICE), London, LON, UK, 5Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Conference/Value in Health Info
Value in Health, Volume 24, Issue 5, S1 (May 2021)
Code
PCN170
Topic
Economic Evaluation, Health Technology Assessment
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis, Decision & Deliberative Processes
Disease
Oncology